Company Analysis Compagnie Financière Richemont SA
1. Summary
Advantages
- Dividends (4.44%) are higher than the sector average (3.14%).
- The company's current efficiency (ROE=11.96%) is higher than the sector average (ROE=-142.93%)
Disadvantages
- Price (152.1 $) is higher than fair price (56.65 $)
- The stock's return over the last year (9.85%) is lower than the sector average (20.02%).
- Current debt level 38.34% has increased over 5 years from 31.94%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
Compagnie Financière Richemont SA | Consumer Cyclical | Index | |
---|---|---|---|
7 days | -3.6% | -3.6% | -1.7% |
90 days | 11.9% | 3.8% | 4.4% |
1 year | 9.8% | 20% | 25.5% |
CFRHF vs Sector: Compagnie Financière Richemont SA has significantly underperformed the "Consumer Cyclical" sector by -10.17% over the past year.
CFRHF vs Market: Compagnie Financière Richemont SA has significantly underperformed the market by -15.62% over the past year.
Stable price: CFRHF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CFRHF with weekly volatility of 0.1894% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (152.1 $) is higher than the fair price (56.65 $).
Price is higher than fair: The current price (152.1 $) is 62.8% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (33.71) is lower than that of the sector as a whole (45.51).
P/E vs Market: The company's P/E (33.71) is lower than that of the market as a whole (53.43).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.86) is higher than that of the sector as a whole (-86.61).
P/BV vs Market: The company's P/BV (3.86) is higher than that of the market as a whole (-9.03).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (3.86) is lower than that of the sector as a whole (6).
P/S vs Market: The company's P/S indicator (3.86) is lower than that of the market as a whole (5.22).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (13.06) is lower than that of the sector as a whole (28.91).
EV/Ebitda vs Market: The company's EV/Ebitda (13.06) is lower than that of the market as a whole (23.53).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -3.03% over the last 5 years.
Accelerating profitability: The return for the last year (654.63%) exceeds the average return for 5 years (-3.03%).
Profitability vs Sector: The return for the last year (654.63%) exceeds the return for the sector (62.63%).
5.4. ROE
ROE vs Sector: The company's ROE (11.96%) is higher than that of the sector as a whole (-142.93%).
ROE vs Market: The company's ROE (11.96%) is higher than that of the market as a whole (-8.22%).
5.5. ROA
ROA vs Sector: The company's ROA (5.65%) is lower than that of the sector as a whole (6.42%).
ROA vs Market: The company's ROA (5.65%) is lower than that of the market as a whole (8.92%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (7.63%) is lower than that of the sector as a whole (12.85%).
ROIC vs Market: The company's ROIC (7.63%) is lower than that of the market as a whole (11.03%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 4.44% is higher than the average for the sector '3.14%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 4.44% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 4.44% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (87.72%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription